Exhausting study
In an article published in the prestigious journal Proceedings of the National Academy of Sciences of the United States of America (PNAS), A/Prof Bala Krishna Murthy turned this concept of immune exhaustion on its head, to stop immune cells from destroying insulin-producing cells in type 1 diabetes.
New hope for type 1 diabetes
An Australian world-first clinical trial published today in the New England Journal of Medicine, has shown that a commonly prescribed rheumatoid arthritis drug can preserve the body’s own insulin production and suppress the progression of type 1 diabetes (T1D) in those newly diagnosed with the condition.
New head at the heart of it
Clinician-researcher Associate Professor André La Gerche has been appointed head of the new Heart, Exercise and Research Trials lab.
New Heart, Exercise and Research Trials lab, powered by partnership with VCCRI
Clinician-researcher Associate Professor André La Gerche has been appointed head of the new Heart, Exercise and Research Trials lab.
The secrets in our genes
We are pleased to announce the appointment of Dr Irene Gallego Romero as Head of SVI’s new Human Genomics and Evolution Laboratory.
Supporting our next generation
SVI's annual For the Love of Science gala dinner raises funds to support our Rising Stars program.
Ahead of the game
A prestigious ARC Fellowship has been awarded to Dr Kim Loh to continue a project that is investigating whether or not a specific protein in the brain could hold the key to curing obesity once and for all.
Inspiring support
A PhD student's passion for one day finding a cure for the cancer that stole her beloved grandmother from her has been inspirational for long-time SVI donors.
A single gene could hold the answer to a number of conditions
Two very talented PhD students have published the results of an impressive research effort into identifying a gene that could hold the key to genetic conditions.
Are elite athletes more at risk from heart disease?
A landmark new study published in Circulation has found that certain genes in elite athletes could also be responsible for a higher risk of heart disease.
Vic Gov’t funding to help halt the progression of blood cancer
Prof Louise Purton has received Victorian Government funding under their mRNA Research Acceleration Fund to continue her work on finding a cure for blood cell cancer.
Rising Star fellow Jarmon Lees
Supported by a Fellowship from the Marian & E.H. Flack Trust, Dr Jarmon Lees and his team from the Cardiac Regeneration Lab are focussed on developing new treatments for its most common complication, heart disease.
Rising Star fellow Jian Kang
As a cancer biologist, Dr Jian Kang has a unique insight into the mechanics of one of the deadliest forms of the disease, ovarian cancer.
Rising Star fellow Kiryu Yap
Dr Kiryu Yap, whose Rising Star Fellowship has been supported by the L.E.W. Carty Signature Grant, is developing cutting edge regenerative medicine techniques to treat liver disease
Gene editing could mean an end to inherited disease
Associate Professor Andrew Deans and his multidisciplinary team have been awarded Victorian Government funding to pioneer the development of RNA-based gene editing technology.
Clinical Trial to explore the use of artificial intelligence in improving breast cancer detection
A clinical trial is currently being developed to support an Australian-led research study examining the use of artificial intelligence in breast cancer screening to improve the accuracy, efficiency and overall patient experience.
Meet Matty, a Fanconi anaemia warrior!
Matty was diagnosed with Fanconi anaemia when he was three months old. Read about him and his hero, his Grandmother "Honey".
Charity Golf Day a hole in one for SVI Research
The effort (and fun) was all worth it – an incredible $160,000 was raised on the day!
Our next generation of excellence
Our next generation of talent: PhD student, Mary Louise Fac's Honours project has been recognised with a Dean's List award.
Diabetes Australia grant supports new generation research
Recent research has shown that Tregs, a particular type of immune cell, control the autoimmune responses that cause type 1 diabetes.